勃起功能障碍:AUA指南
指南以共同决策为核心,强调应向所有患者告知未被禁忌的全部治疗方式,不论其侵入性或不可逆性,均可作为潜在一线治疗。
要点
- 以共同决策为诊疗基石,向患者告知所有未禁忌的治疗选择。
- 不因侵入性或不可逆性排除任何治疗作为潜在一线方案。
- 每项治疗需确保患者及其伴侣充分理解获益与风险/负担。
核心结论
- 以共同决策为核心,所有未禁忌的治疗方式均可作为潜在一线治疗,不论侵入性或不可逆性。
研究设计与样本
- 证据陈述基于A、B或C级证据强度,分别标定为强、中、条件性推荐,并以临床原则或专家意见形式补充。
主要发现
- 制定了勃起功能障碍管理的循证指南,并设计为与配套治疗算法联合使用。
关键数值与推荐
- 证据体强度分为A、B、C级,推荐等级为强、中、条件性推荐,另有临床原则与专家意见。
临床怎么用
- 临床应以共同决策为基石,向所有患者告知未被禁忌的全部治疗方式,并确保患者及其伴侣充分理解各选择的获益与风险/负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this guideline is to provide a clinical strategy for the diagnosis and treatment of erectile dysfunction. MATERIALS AND METHODS: A systematic review of the literature using the Pubmed, Embase, and Cochrane databases (search dates 1/1/1965 to 7/29/17) was conducted to identify peer-reviewed publications relevant to the diagnosis and treatment of erectile dysfunction. Evidence-based statements were based on body of evidence strength Grade A, B, or C and were designated as Strong, Moderate, and Conditional Recommendations with additional statements presented in the form of Clinical Principles or Expert Opinions. RESULTS: The American Urological Association has developed an evidence-based guideline on the management of erectile dysfunction. This document is designed to be used in conjunction with the associated treatment algorithm. CONCLUSIONS: Using the shared decision-making process as a cornerstone for care, all patients should be informed of all treatment modalities that are not contraindicated, regardless of invasiveness or irreversibility, as potential first-line treatments. For each treatment, the clinician should ensure that the man and his partner have a full understanding of the benefits and risk/burdens associated with that choice.
引用
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018. PMID: 29746858. doi:10.1016/j.juro.2018.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。